ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012

In Brief: CRCC, One Of The 21 Comprehensive Centers, To Close Up; Steckel New AACI President

January 30, 1981

HEW Money Bills Mark Up Set May 26

May 20, 1977

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

July 30, 2004

Sen. Edward Kennedy Receives ACS Medal

January 23, 2009

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002